Back to my company list

New

PrediScan

The AI engine Fit Assessment

Beta

The company operates in AI for healthcare, developing clinical decision support for early cardiovascular risk triage in hospital OPDs.

Blurb

Developer of a medical imaging and risk assessment platform designed for the early non-invasive screening of non-communicable diseases. The company's platform utilizes artificial intelligence to analyze fundus images from various existing cameras, providing rapid screening for heart, kidney, and liver conditions through a device-agnostic system trained specifically on regional health data to identify risks without requiring blood tests or radiation, enabling healthcare providers and medical facilities to detect early-stage disease progression and improve patient outcomes through streamlined, large-scale health monitoring.

HQ Location

Chennai (India)

Founded

2023

Employees

11 - 50

Total funding raised

Not available

Funding Status

Not available

PrediScan MedTech is a healthcare AI company building clinical decision support software for early cardiovascular risk triage in hospital OPDs.



Our platform integrates into routine OPD workflows and provides instant, non-invasive cardiovascular risk flags at the point of care, enabling doctors to make informed decisions on further diagnostics or referrals before the patient leaves the hospital.



PrediScan is designed for real-world hospital adoption:

~ Zero disruption to existing OPD processes

~ Doctor-in-the-loop decision support (not automated diagnosis)

~ Usage-based B2B SaaS pricing aligned with hospital ROI



We work closely with hospitals to improve early risk identification, optimize diagnostic conversion, and support better cardiovascular outcomes at scale.



PrediScan is backed by IIT Madras Incubation Cell (IITMIC), IIMV FIELD.